Market Size –
The narcolepsy market size has grown rapidly in recent years. It will grow from $3.19 billion in 2023 to $3.56 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increased awareness of narcolepsy, the development, and improvement of diagnostic tools, the introduction of new pharmacological treatments, research and development investments, and enhanced patient education initiatives.
The narcolepsy market size is expected to see rapid growth in the next few years. It will grow to $5.57 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to the rising prevalence of sleep disorders, improved healthcare infrastructure, supportive government policies, an increasing geriatric population, and rising consumer health awareness. Major trends in the forecast period include advancements in genetic research, technological innovations in diagnostics, the introduction of novel drugs and treatment modalities, strategic collaborations and partnerships between key market players, and digital health tools and telemedicine.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/narcolepsy-global-market-report
Scope Of Narcolepsy Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Narcolepsy Market Overview
Market Drivers –
The growing number of obese people is expected to propel the growth of the narcolepsy market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat, which poses a health risk. The number of obese people is rising due to increasingly sedentary lifestyles, poor dietary habits, and environmental factors that promote calorie-dense food consumption and reduce physical activity. Obesity can contribute to narcolepsy by disrupting metabolic and hormonal balances, potentially leading to changes in sleep patterns and the regulation of wakefulness. For instance, in March 2022, according to the World Health Organization, a Switzerland-based specialized United Nations agency responsible for worldwide public health, around 1 billion individuals, comprising 650 million adults, 340 million teenagers, and 39 million children, were classified as obese, with this figure continuing to rise. Projections indicate that by 2025, approximately 167 million adults and children will suffer health consequences due to excess weight. Therefore, the growing number of obese people is driving the growth of the narcolepsy market.
Market Trends –
Major companies operating in the narcolepsy market are increasing their focus on developing novel medications, such as extended-release sodium oxybate, to address the growing demand for effective treatments. Extended-release sodium oxybate is a medication used in the treatment of narcolepsy. The extended-release formulation allows for controlled release of the medication over a longer period, providing sustained symptom relief throughout the night and improving sleep quality for individuals with narcolepsy. For instance, in June 2023, Avadel Pharmaceuticals plc, an Ireland-based pharmaceutical company, launched LUMRYZ in the United States. LUMRYZ is an extended-release formulation of sodium oxybate approved by the FDA for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. It is the first and only once-at-bedtime oxybate treatment for narcolepsy, offering a significant improvement over twice-nightly oxybate products by avoiding the need to wake up for a second dose at night.
The narcolepsy market covered in this report is segmented –
1) By Type: Type 1, Type 2
2) By Treatment: Antidepressants, Stimulants, Sodium Oxybate, Other Treatments
3) By Diagnosis: Poysomnogram, Multiple Sleep Latency Test
4) By End Users: Hospitals, Retail Pharmacies, Other End Users
Get an inside scoop of the narcolepsy market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16491&type=smp
Regional Insights –
North America was the largest region in the narcolepsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the narcolepsy market are Pfizer Inc., Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Viatris Inc, Teva Pharmaceutical Industries, Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Ono Pharmaceutical Co. Ltd, Lupin Pharmaceuticals, Alkermes, Harmony Biosciences, Arena Pharmaceuticals, Cerevel Therapeutics, Axsome Therapeutics Inc., Avadel Pharmaceuticals, NLS Pharmaceutics AG, KemPharm, Suven Life Sciences Ltd
Table of Contents
1. Executive Summary
2. Narcolepsy Market Characteristics
3. Narcolepsy Market Trends And Strategies
4. Narcolepsy Market – Macro Economic Scenario
5. Global Narcolepsy Market Size and Growth
.
.
.
31. Narcolepsy Market Other Major And Innovative Companies
32. Global Narcolepsy Market Competitive Benchmarking
33. Global Narcolepsy Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Narcolepsy Market
35. Narcolepsy Market Future Outlook and Potential Analysis
36.Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
